Panhematin Powder, For Solution
Product Images NDC 55292-702

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Panhematin (NDC 55292-702). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Recordati Rare Diseases, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton

This appears to be a product information sheet for Hemin For Injection, also known as Panhematin®. It includes information on the contents of the package, including hemin per vial, instructions for intravenous infusion only, and sterile powder for injection. The text also includes a product code, a rare diseases indication, and storage instructions. There are several sections with illegible characters or partially cut off text.*

FDA Label Image

Structural Formula Of Hemin (Image 01)

FDA Label Image

Clinical Response After Hemin Therapy (Image 02)

FDA Label Image

Label

This text is related to a caution regarding administration of a medication which requires to consult the package insert for full prescribing information. There is a warning about a substance "laex" present in the vialstopper. The medication needs to be used immediately after mixing and any unused portion should be discarded. There are some unreadable characters towards the end of the text.*

FDA Label Image

Logo

Recordati is a company that specializes in rare diseases. That is the only information provided in the text.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.